Latest Valuation News

Arovella Therapeutics has requested a voluntary suspension of its ASX-listed securities pending a material announcement on a capital raising, expected by 17 February 2025.

Generation Development Group Limited (ASX:GDG) has announced a $320 million acquisition of Evidentia Group Holdings, aiming to consolidate its position as a leader in Australia's managed accounts market. The deal is supported by a fully underwritten $287.9 million equity raising and promises immediate earnings accretion.

Scorpion Minerals Limited has voluntarily suspended trading of its shares as it finalises a capital raising and a potential joint venture agreement, signaling significant corporate developments ahead.

Dexus Convenience Retail REIT (ASX: DXC) reported steady half-year results for 2025, underpinned by active portfolio management and ongoing redevelopment projects. The fund remains on track to meet full-year guidance while enhancing income security and growth potential.

Dexus Convenience Retail REIT reported solid half-year results for FY25, maintaining distribution guidance while enhancing portfolio quality through strategic divestments and commencing a major redevelopment at Glass House Mountains.

Dexus Convenience Retail REIT has rebounded strongly with a $14.7 million net profit for the half-year ending December 2024, underpinned by a resilient portfolio and active redevelopment plans.

Barton Gold has confirmed significant depth extensions at its Tunkillia Project's 223 Deposit, with new drilling intersecting broad mineralisation below the previously modelled pit floor. This discovery supports an expanded resource estimate and ongoing optimisation studies.

Patronus Resources has initiated an on-market takeover offer for Matsa Resources at $0.045 per share, representing a significant premium and aiming to consolidate its position in gold exploration.

Gorilla Gold has announced the discovery of a new, high-grade gold lode north of the existing resource at its Comet Vale Project, signaling significant growth potential. Multiple drill intercepts confirm a continuous gold zone from surface, underpinning the company’s aggressive expansion strategy.

Cleo Diagnostics has responded to an ASX price query following a notable rise in its share price and trading volume, underscoring its patented ovarian cancer detection technology and ongoing U.S. clinical trials.

Xstate Resources has divested its 25% stake in the Crest Jinn assets in Alberta, Canada, opting for a modest royalty interest as it refocuses amid geopolitical and operational uncertainties.

PM Capital Global Opportunities Fund has declared a 5.5 cent fully franked interim dividend for H1 FY25 and reaffirmed its commitment to an 11.0 cent annual dividend, supported by a 6.0% portfolio return for the year ending December 2024.